机译:Toll样受体3-TICAM-1(TRIF)途径在髓样树突状细胞中诱导抗肿瘤NK激活
Osaka Med Ctr, Dept Immunol, Higashinari Ku, Osaka 5378511, Japan;
Osaka Med Ctr, Dept Mol Genet, Higashinari Ku, Osaka 5378511, Japan;
Osaka Med Ctr, Dept Mol Biol, Higashinari Ku, Osaka 5378511, Japan;
Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Sapporo, Hokkaido 0608638, Japan;
Nara Inst Sci & Technol, Dept Mol Immunol, Nara 6310101, Japan;
Aichi Canc Ctr, Res Inst, Div Immunol, Nagoya, Aichi 4648684, Japan;
Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan;
antitumor immunity; type; interferon; syngenic tumor; implant model; gene-disrupted mice; DOUBLE-STRANDED-RNA; NATURAL-KILLER-CELLS; IMMUNE-RESPONSES; ANTIVIRAL RESPONSES; SIGNALING PATHWAY; ADAPTER MOLECULE; VIRAL-INFECTION; INTERFERON-BETA; INNATE IMMUNITY; CROSS-TALK;
机译:空肠弯曲杆菌诱导的树突状细胞激活涉及通过Toll样受体4(TLR4)-MyD88和TLR4-TRIF轴的协作信号。
机译:协同的toll样受体激活的树突状细胞诱导表达癌胚抗原的结肠癌具有抗肿瘤作用
机译:协同的toll样受体激活的树突状细胞诱导表达癌胚抗原的结肠癌具有抗肿瘤作用
机译:树突状细胞中的收费受体的临界功能
机译:Toll样受体配体激活的树突状细胞对人CD4 + T细胞反应的影响。
机译:Toll样受体3-TICAM-1(TRIF)途径在髓样树突状细胞中诱导抗肿瘤NK激活
机译:Toll样受体3-TICAM-1(TRIF)途径在髓样树突状细胞中诱导抗肿瘤NK激活